Companies: 10,795·Total market cap: $144.5T
Fielmann AG

Fielmann AG

FLMNYOTCHealthcare● Active
$10.13
+$0.20(+1.96%)
Market Cap$4.3B
P/E Ratio
52W High$14.17
52W Low$9.5
Overview

Fielmann AG(FLMNY)股票概览

关键指标与盈利、估值、营收、股息等标签页深链。

FMP · FLMNY · 截至 Jun 9, 2026

关键指标

EPS (TTM)$0.46flmny eps ttm · flmny earnings per shareEarnings history
PE Ratio (TTM)22.0×flmny pe ratio ttm · flmny price to earningsPE Ratio deep dive
Revenue (TTM)$2.3Bflmny revenue ttm · flmny annual revenueFull revenue history
Dividend Yield1.89%does flmny pay dividends · flmny dividend yieldDividend history
Shares Outstanding419.8Mflmny shares outstanding · flmny floatShares outstanding history
Next EarningsTBAflmny earnings date · flmny next earningsEarnings history

财务快照

完整财报
FY 2025Revenue$2.34B▲ +3.32% YoY
202320242025
fielmann ag revenue · flmny revenue 2025
FY 2025Net Income$195.7M▲ +28.65% YoY
202320242025
fielmann ag net income · flmny profit 2025
FY 2025EPS$0.47▲ +30.56% YoY
202320242025
flmny eps · fielmann ag earnings per share 2025
TTM:Revenue: $2.34BNet Income: $195.7MEPS: $0.46View income statement →

股票表现

完整历史
1D+1.96%
1W+1.91%
1M+1.91%
3M+1.91%
YTD-0.69%
1Y-20.86%
5Y-37.28%

关于 Fielmann AG

CEOMarc Fielmann
IPO DateMar 21, 2017
Employees20,221
CountryDE

Fielmann AG Fielmann Aktiengesellschaft is a leading German company primarily involved in the retail and investment aspects of the optical and audiological sectors. Its product portfolio encompasses a broad selec…

what is fielmann ag · flmny stock overview · fielmann ag company profile · who is fielmann ag ceo · flmny OTC · fielmann ag headquarters · fielmann ag business segments

关于股票概览与关键数据

Fielmann AG(FLMNY)是 Medical - Instruments & Supplies 行业的 Healthcare 类公司,于 Mar 21, 2017 在 OTC 上市。截至最近交易日,FLMNY 股价为 $10.13,市值约为 $4.3B。过去12个月累计回报 -20.86%,年初至今回报 -0.69%。

2025 财年 Fielmann AG 营收 $2.3B。完整财务数据(营收历史、盈利、资产负债表)请使用上方标签页。

常见问题

截至最近一个交易日,Fielmann AG(FLMNY)股价为 $10.13,在 OTC 上市,52周区间为 $9.50 – $14.17。

FLMNY 最新股价FLMNY quote todaylive ticker 实时行情
数据来源:Financial Modeling Prep最后更新:Jun 9, 2026本内容不构成投资建议